-
TFI International Inc. (TFII $122.18)
-
Celsius Holdings Inc. (CELH $44.37)
-
TransMedics Group Inc. (TMDX $106.01)
We have some recent comments on TFII; we think it will be fine, but much is going to depend on tariffs and the economy here. The others are showing excellent momentum this year. CELH is up 32%, TMDX is up 45%. Both are expected to show strong earnings growth this year. TMDX in the 50% range, CELH about 35%. Balance sheets are fine here. CELH is 36X earnings, TMDX is 61X. They are still vulnerable if there is a growth or market hiccup, but we would be more comfortable here with positive momentum than before when both were melting. We would still consider all these decent companies, with CELH and TMDX more skewed to growth, vs TFII which is closely tied to factors beyond its control. Overall, despite the comments above, TFII might be the 'safest' with a much lower valuation. The others though may still provide significant upside under good conditions, and if we think an investor has held these strongly through the downturn now would not be the time to sell.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in CELH.